Comparison Between Dexmedetomidine and Propofol on Outcomes After Coronary Artery Bypass Graft Surgery

A Retrospective Study

Jie Hu; Bingfeng Lv; Raha West; Xingpeng Chen; Yali Yan; Chen Pac Soo; Daqing Ma


BMC Anesthesiol. 2022;22(51) 

In This Article


Our findings suggest that DEX may reduce short term postoperative pulmonary complications, time on mechanical lung ventilation, ICU and hospital stay following CABG surgery compared to propofol. Our work, reported here, may provide a rationale for further prospective clinical studies investigating the benefits of DEX, including other intraoperative outcomes such as the benefit on surgical time or long-term outcomes such as 30 days mortality following CABG surgery.